Pericardial syndromes: an update after the ESC guidelines 2004

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Syndromes

Background:

• Pericardial diseases manifest in limited clinical syndromes despite diverse etiologies.
• Acute pericarditis requires differentiation from various cardiopulmonary and gastrointestinal conditions.
• Identifying high-risk features is crucial for determining appropriate patient management and hospitalization.

Purpose of the Study:

• To differentiate acute pericarditis from other conditions.
• To identify high-risk features necessitating hospitalization.
• To outline current treatment strategies for acute, recurrent, and constrictive pericarditis.

Main Methods:

• Clinical differentiation of acute pericarditis from mimics.
• Assessment of high-risk features for hospitalization.
• Pharmacological treatment with NSAIDs and colchicine.
• Echo-guided pericardiocentesis for tamponade.
• Diagnostic procedures like pericardioscopy and biopsy for etiological clarification.
• Imaging and hemodynamic assessment for constrictive pericarditis.

Main Results:

• Non-steroidal anti-inflammatory drugs (NSAIDs) plus colchicine form the primary treatment for acute pericarditis.
• Corticosteroids are generally avoided due to recurrence risk, except in autoimmune cases.
• Pericardiocentesis is indicated for tamponade or large effusions; biopsy aids etiological diagnosis.
• Recurrent pericarditis may require advanced therapies including biologics like anakinra.
• Pericardiectomy is reserved for severe, chronic constrictive pericarditis.

Conclusions:

• Effective management of pericardial diseases relies on accurate diagnosis and risk stratification.
• Standard treatment involves NSAIDs and colchicine, with corticosteroids reserved for specific indications.
• Advanced therapies and surgical intervention are options for refractory or severe cases.
• Understanding predictors of poor survival is vital for managing constrictive pericarditis.